Project Power: An HIV Risk Reduction Intervention for Black Men Who Have

Status Completed

Clinical Trial Summary

The goal of this study is to develop and test a program to help Black men who have sex with men and women reduce their chances of getting or giving HIV infection to their sex partners. The program is designed to be delivered via the internet so that it would be available to more men. Men who agree to participate in the study will be assigned by chance to receive the POWER intervention or a similar program that is focused on general health called POWER-HEALTH. They will also complete a computer administered interview when they first enroll in the study, 2 weeks following the last session of the program and 3 months after that. Participants will receive a small compensation for their time and effort.

Clinical Trial Description

The purpose of this study is to examine the preliminary efficacy, feasibility and acceptability of delivering a culturally and developmentally tailored HIV risk reduction intervention via the Internet in real-time that promotes risk reduction among black men who have sex with men and women (BMSMW). During the Developmental Phase, our activities will consist of completing development (finalizing sessions, completing the manuals) of a theoretically grounded, culturally based, individual intervention, Project POWER, to reduce risk of HIV acquisition and transmission among BMSMW.

The investigators will then conduct a randomized controlled trial (RCT) to test the preliminary efficacy, acceptability, and feasibility of POWER compared to HEALTH. Using chain referral methods, the investigators will recruit 200 BMSMW (100 per arm) and assign them to 1 of 2 conditions (POWER or HEALTH). Participants will complete an assessment battery delivered via ACASI at baseline, immediate post intervention and at 3 months post intervention. The investigators will also measure uptake of HIV and STI testing. Participants will also complete acceptability/feasibility assessments after the ;

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Single Blind (Subject), Primary Purpose: Prevention

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT01376895
Study type	Interventional
Source	Nova Southeastern University
Contact
Status	Completed
Phase	Phase 1/Phase 2
Start date	July 2011
Completion date	March 2014

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT05009251` - Using Explainable AI Risk Predictions to Nudge Influenza Vaccine Uptake	N/A
Completed	`NCT05509270` - Efficacy of Communication Modalities for Promoting Flu Shots	N/A
Completed	`NCT05343208` - Effectiveness of Online Therapy to Prevent Burnout	N/A
Completed	`NCT03833713` - Utilizing Text Messaging to Improve Vehicle Safety Among At-Risk Young Adults	N/A
Recruiting	`NCT06001892` - Tennessee Youth Prepared for Success	N/A
Completed	`NCT04323137` - Encouraging Flu Vaccination Among High-Risk Patients Identified by ML	N/A
Recruiting	`NCT03109899` - Personalized HIV and STI Testing Tool	N/A
Recruiting	`NCT05017948` - Alleviating Geriatric Inpatients' Medication-related Iatrogenesis	N/A
Completed	`NCT05509283` - Nudging Flu Vaccination in Patients at Moderately High Risk for Flu and Flu-related Complications	N/A
Recruiting	`NCT05353283` - PrEP Point-of-Care Brief-Intervention for Adherence Among Young Men Who Have Sex With Men	N/A
Recruiting	`NCT04294381` - Achievement and Adherence to Behavioral Health Goals in the Setting of Patient-Directed Goal Choice	N/A
Recruiting	`NCT04500977` - Training Health Promotion Women Community Leaders	N/A
Recruiting	`NCT03319927` - Reducing Pesticide Exposures in Child Care Centers	N/A
Completed	`NCT03981952` - Salmonella Conjugates CVD 1000: Study of Responses to Vaccination With Trivalent Invasive Salmonella Disease Vaccine	Phase 1
Completed	`NCT03177512` - LYNX: A Novel Mobile App to Support Linkage to HIV/STI Testing PrEP for Young Men Who Have Sex With Men	N/A
Recruiting	`NCT04374747` - Fruit and Vegetable Intervention in Lactating Women to Reduce Breast Cancer Risk	N/A
Recruiting	`NCT06020469` - Comparative Effects of Ciprofol and Propofol on Pain Intensity on the First Day After Surgery: a Retrospective, Propensity Score Matched, Cohort Study
Recruiting	`NCT05569460` - Construction of Perioperative Medical Data Platform and Its Typical Practice to Predict Postoperative Acute Moderate to Severe Pain With Machine Learning Models
Not yet recruiting	`NCT03222960` - Improving Caries Risk Using Propolis-containing Versus Fluoride-containing Toothpastes in High Caries Risk Patients	N/A
Completed	`NCT03965221` - Comparison of Men's Prevention Apps to Research Efficacy	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Project Power: An HIV Risk Reduction Intervention for Black Men Who Have Sex With Men and Women (BMSM/W) — Power

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms